-
公开(公告)号:WO2019089147A1
公开(公告)日:2019-05-09
申请号:PCT/US2018/051806
申请日:2018-09-19
申请人: FIBROGEN, INC.
IPC分类号: A61K39/395 , A61K45/06 , C07K16/22
CPC分类号: C07K16/22 , A61K2039/505 , A61P11/00 , C07K2317/24 , A61K2300/00
摘要: The present invention relates to methods and medicaments useful for treating idiopathic pulmonary fibrosis (IPF) by administering an anti-CTGF antibody. In particular, the treatment methods provided avoid toxicities associated with approved therapies and also avoid the attenuation of the efficacy of an anti-CTGF antibody caused by these approved therapies.